The therapeutic effects of baicalin on vitiligo mice

N/ACitations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Vitiligo is a commom disease of skin. Its pathogenesis is complex, resulting in the incapacity to find a targeted cure. Baicalin, which is isolated from Scutellariae radix, has been known to exhibit a number of pharmacological effects on autoimmune diseases. In this study, we explored the effects of Baicalin on the recovery of vitiligo stimulated by monophe-nylketone in mice. We observed that Baicalin slowed down the progression of depigmentation, decreased the incidence of depigmentation, and reduced the area of depigmentation. Moreover, reflectance confocal microscopy (RCM) shown that Baicalin increased the epidermal melanocytes in depigmented skin. Baicalin decreased CD8+T cell infiltration in mice skin, and decreased the expression of CXCL10 and CXCR3. Baicalin significantly decreased the levels of serum cytokine (interleukin [IL]-6, tumor necrosis factor [TNF]-α, interferon-γ [IFN-γ], and IL-13). Collectively, these data suggest that Baicalin play an important role in the occurrence and development of vitiligo.

Author supplied keywords

Cite

CITATION STYLE

APA

Zhu, Y., Zhong, L., Peng, J., Yuan, Q., & Xu, A. (2019). The therapeutic effects of baicalin on vitiligo mice. Biological and Pharmaceutical Bulletin, 42(9), 1450–1455. https://doi.org/10.1248/bpb.b19-00319

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free